IVVD logo
IVVD NASDAQ US

Invivyd, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Aug 2021
$1.28
▼ $-0.05 (-3.76%)
Vol 3.9M
4
Quality Score
fail
Mkt Cap
$684.5M
ROE
-93.0%
Margin
-119.6%
D/E
0.00
Beta
0.69
52W
$0–$3

Wall Street Consensus

10 analysts · Apr 2026
3
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
80.0%
Buy Rating

Price Chart

Similar Stocks

AKBA
Akebia Therapeutics Inc
$427.2M
MNPR
Monopar Therapeutics Inc
$436.4M
CADL
Candel Therapeutics Inc
$310.2M
IMRX
Immuneering Corp
$424.9M
PBYI
Puma Biotechnology Inc
P/E 8.1
$299.8M
DMAC
DiaMedica Therapeutics Inc
$414.5M
CABA
Cabaletta Bio Inc
$210.8M
XOMA
Xoma Royalty Corp
P/E 15.2
$329.3M

Earnings

Beat rate: 50.0%
Next Report May 13, 2026
EPS Estimate: $-0.07
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.07 — —
Dec 2025 $-0.09 $-0.04 +$0.05
Sep 2025 $-0.08 $-0.06 +$0.02
Jun 2025 $-0.02 $-0.12 $-0.10

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -177.9% -165.2% -177.9% -177.9% -93.0% -93.0%
P/E (TTM) — — — — — —
Net Margin -124.4% -389.0% -238.3% -238.3% -119.6% -119.6%
Gross Margin 94.2% 93.3% 93.4% 93.4% 93.3% 93.3%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.33 1.53 1.33 1.33 2.47 2.47

Key Ratios

ROA (TTM)
-51.9%
P/S (TTM)
13.68
P/B
0.8
EPS (TTM)
$-0.47
52W High
$3.07
52W Low
$0.35
$0.35 52-Week Range $3.07

How does IVVD compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

IVVD AAPG ABEO ABOS ABP

IVVD valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
13.7
▲ 6% above peers (12.9)
vs Peers
vs Industry
Fair value
P/B ratio
0.8
▼ 68% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

IVVD profitability vs Biotechnology peers

ROE
-93.0%
▼ 38% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-119.6%
▲ 58% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
93.3%
▲ 19% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-51.9%
▼ 11% below peers (-46.7%)
vs Peers
vs Industry
In line

IVVD financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.5
▼ 44% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
▼ 28% below peers (1.0)
vs Peers
vs Industry
More volatile

IVVD fundamentals radar

IVVD Peer median Industry

IVVD profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

IVVD vs peers: key metrics

Latest News

No related news yet